AstraZeneca PLC (AZN)
Health Care
AstraZeneca PLC (AZN) is listed on the New York Stock Exchange, where its shares have traded since October 23, 2009. SentiSense covers AstraZeneca PLC in the Health Care sector. Pascal Soriot is its chief executive officer. The company reports 96,100 employees, and its corporate website is www.astrazeneca.com.
About AstraZeneca PLC
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999. The firm sells branded drugs across a number of major therapeutic areas, including oncology (over 40% of total revenue), cardiovascular, renal, and metabolic (over 20%), rare disease (16%), and respiratory and immunology (15%). The majority of sales comes from international markets, with the United States representing close to one-third of its sales.
Latest reported results
AstraZeneca PLC reported revenue of $15.99 billion for Q3 FY2026, up 5.3% from the same period a year earlier.
Institutional ownership
In 13F filings for the quarter ended June 30, 2026, 1,470 institutions reported holding AZN, with 789.4 million shares worth $148.3 billion in aggregate. The largest reported holders were Vanguard, Capital Group and Investor AB. Of the 5 largest reported holders, 1 opened a new position in AZN, 2 added shares, 1 reduced its position and 1 held its position unchanged during the quarter.
More on AZN
- AZN sentiment: whether news and social coverage of AstraZeneca PLC leans bullish or bearish, and the stories driving it.
- AZN ownership: all 1,470 reporting institutions, plus insider and congressional trades.
- AZN financials: revenue, net income, operating margin and free cash flow through Q3 FY2026.
SentiSense also tracks daily options readings for AstraZeneca PLC: IV rank, put/call percentile, 25-delta skew and open-interest walls.
Frequently asked questions
What does AstraZeneca PLC do?
A merger between Astra of Sweden and Zeneca of the United Kingdom formed AstraZeneca in 1999.
What sector is AZN in?
SentiSense classifies AstraZeneca PLC in the Health Care sector.
Where does AZN stock trade?
AstraZeneca PLC (AZN) is listed on the New York Stock Exchange, where its shares have traded since October 23, 2009.
Who is the CEO of AstraZeneca PLC?
Pascal Soriot is the chief executive officer of AstraZeneca PLC.